Immunologic Aspects of Melanoma

References

• Cutler S. J., Young J. L. Third national cancer survey: incidence data. Nail. Cancer Inst. Monogr. March, 1975; 41
   Google Scholar
• Lee J. A. H. Fatal melanoma of the lower limbs and other sites: an epidemiologic study. J. Nail. Cancer Inst. 1970; 44: 257
   Google Scholar
• Lee J. A. H., Carter A. P. Secular trends in mortality from malignant melanoma. J. Natl. Cancer Inst. 1970; 45: 91
   PubMedGoogle Scholar
• Cosman B., Heddle S. B., Crikelair G. F. The increasing incidence of melanoma. Plast. Reconstr. Surg. 1976; 57: 50
   Google Scholar
• Houghton A., Munster E. W., Viola M. V. Increased incidence of malignant melanoma after peaks of sunspot activity. Lancet 1978; 1: 759
   PubMed Web of Science ®Google Scholar
• 1977 Cancer Facts and Figures. New York American Cancer Society. 1976
   Google Scholar
• Pollack E. S., Horm J. W. Trends in cancer incidence and mortality in the United States, 1969–76. J. Natl. Cancer Inst. 1980; 64: 1091
   PubMed Web of Science ®Google Scholar
• Moore G. E., Moore M. B. Auto-inoculation of cultured human lymphocytes in malignant melanoma. N.Y. State J. Med. 1969; 69: 460
   PubMedGoogle Scholar
• McCarthy W. H., Cotton G., Carlon A., Milton G. W., Kossard S. Immunotherapy of malignant melanoma. Cancer 1973; 32: 97
   Google Scholar
• Gutterman J., Mavligit G., McBride C, Frei E., Hersh E. M. BCG stimulation of immune responsiveness in patients with malignant melanoma. Cancer 1973; 32: 321
   PubMed Web of Science ®Google Scholar
• Seigler H. F., Shingleton W. W., Pickrell K. I. Intralesional BCG, intravenous immune lymphocytes, and immunization with neura-minidase-treated tumor cells to manage melanoma. Plast. Reconst. Surg. 1975; 55: 294
   PubMed Web of Science ®Google Scholar
• Morton D. L., Eilber F. R., Holmes E. C., Sparks F. C., Raunning K. P. Present status of BCG immunotherapy of malignant melanoma. Cancer Immunol. Immunother. 1976; 1: 93
   Google Scholar
• Gross L. Intradermal immunization of C3H mice against a sarcoma that originated in an animal of the same line. Cancer Res. 1943; 3: 326
   Google Scholar
• Foley E. J. Antigenic properties of methylcholanthrene-induced tumors in mice of the strain of origin. Cancer Res. 1953; 13: 835
   PubMed Web of Science ®Google Scholar
• Prehn R. T., Main J. M. Immunity to methylcholanthrene-induced sarcomas. J. Natl. Cancer Inst. 1957; 18: 769
   PubMed Web of Science ®Google Scholar
• Klein G., Sjogren H. O., Klein E., Hellstrom K. E. Demonstration of resistance against methylcholanthrene-induced sarcomas in the primary autochthonous host. Cancer Res. 1960; 20: 1561
   PubMed Web of Science ®Google Scholar
• Invernizzi G., Parmiani G. Tumor-associated transplantation antigens of chemically induced sarcomata cross reacting with allogeneic histocompatability antigens. Nature 1975; 254: 713
   PubMedGoogle Scholar
• Garrido F., Festenstein H., Schirrmacher V. Further evidence for derepression of H-2 and la-like specificities of foreign haplotypes in mouse tumour lines. Nature 1976; 261: 705
   Google Scholar
• Meschini A., Invernizzi G., Parmiani G. Expression of alien H-2 specificities on a chemically induced BALB/c fibrosarcoma. Int. J. Cancer 1977; 20: 271
   Google Scholar
• Rogers M. J., Appella E., Pierotti M. A., Invernizzi G., Parmiani G. Biochemical characterization of alien H-2 antigens expressed on a methylcholanthrene-induced tumor. Proc. Natl. Acad. Sci. U.S.A. 1979; 76: 1415
   Google Scholar
• Rogers M. J., Law L. W., Pierotti M. A., Parmiani G. Separation of the tumor-associated transplantation antigen (TATA) from the alien H-2 antigens expressed on a methylcholanthrene-induced tumor. Int. J. Cancer 1980; 25: 105
   Google Scholar
• Deleo A. B., Shiku H., Takahashi T., John M., Old L. F. Cell surface antigens of chemically induced sarcomas of the mouse. 1. Murine leukemia virus-related antigens and alloantigens on cultured fibroblasts and sarcoma cells: description of a unique antigen on BALB/c Meth A sarcoma. J. Exp. Med. 1977; 146: 720
   PubMed Web of Science ®Google Scholar
• Deleo A. B., Shiku H., Takahashi T., Old L. J. Serological definition of cell surface antigens of chemically induced sarcomas of inbred mice. Biological Markers of Neoplasia: Basic and Applied Aspects, R. Ruddon. Elsevier, New York 1978; 25
   Google Scholar
• Gross L. A filterable agent, recovered from Ak leukemic extracts, causing salivary gland carcinomas in C3H mice. Proc. Soc. Exp. Biol. Med. 1953; 83: 414
   PubMed Web of Science ®Google Scholar
• Eddy B. E., Stewart S. E., Berkeley W. Cytopathogenicity in tissue cultures by a tumor virus from mice. Proc. Soc. Exp. Biol. Med. 1958; 98: 848
   PubMed Web of Science ®Google Scholar
• Sjogren H. O., Hellstrom I., Klein G. Resistance of polyoma virus immunized mice to transplantation of established polyoma tumors. Exp. Cell Res. 1961; 23: 204
   Google Scholar
• Habel K. Resistance of polyoma virus immune animals to transplantable polyoma tumors. Proc. Soc. Biol. Med. 1961; 106: 722
   PubMed Web of Science ®Google Scholar
• Jawetz E., Melnick J. L., Adelberg E. A. Oncogenic viruses. Review of Medical Microbiology13th ed., E. Jawetz, J. L. Melnick, E. A. Adelberg. Lange, Los Altos, Calif 1978; 462
   Google Scholar
• Nowinski R. C., Old L. J., Sarkar N. H., Moore D. H. Common properties of the oncogenic RNA viruses (oncornaviruses). Virology 1970; 42: 1152
   PubMed Web of Science ®Google Scholar
• Baltimore D. Viruses, polymerases and cancer. Science 1976; 192: 632
   PubMed Web of Science ®Google Scholar
• Temin H. The DNA provirus hypothesis: the establishment and implications of RNA-directed DNA synthesis. Science 1976; 192: 1075
   PubMed Web of Science ®Google Scholar
• Dulbecco R. From the molecular biology of oncogenic DNA viruses to cancer. Science 1976; 192: 437
   PubMed Web of Science ®Google Scholar
• Rous P. Transmission of a malignant new growth by means of a cell free filtrate. JAMA 1911; 56: 198
   Google Scholar
• Gross L. Development and serial cell free passage of a highly potent strain of mouse leukemia virus. Proc. Soc. Exp. Biol. Med. 1957; 94: 767
   PubMed Web of Science ®Google Scholar
• Graffi A. Chloroleukemia of mice. Am. N.Y. Acad. Sci. 1957; 68: 540
   Google Scholar
• Friend C. Cell-free transmission in adult swiss mice of a disease having the character of leukemia. J. Exp. Med. 1957; 105: 307
   PubMedGoogle Scholar
• Bittner J. J. Mammary cancer in fostered and unfostered C3H breeding females and their hybrids. Cancer Res. 1943; 3: 441
   Google Scholar
• Jarrett W. F. H., Martin W. B., Crighton G. W., Dalton R. G., Stewart M. F. Leukemia in the cat. Transmission experiments with leukemia (lymphosarcoma). Nature 1964; 202: 566
   PubMed Web of Science ®Google Scholar
• Jarrett W. F. H., Crawford E. M., Martin W. B., Davie F. Leukemia in the cat. A virus-like particle associated with leukemia (lymphosarcoma). Nature 1964; 202: 567
   PubMed Web of Science ®Google Scholar
• Hardy W. D., Jr, Geering G., Old L. J., DeHarven E. Feline leukemia virus: occurrence of viral antigen in the tissues of cats with lymphosarcoma and other disease. Science 1969; 166: 1019
   PubMed Web of Science ®Google Scholar
• Hardy W. D., Jr. Feline lymphosarcoma: a model of viral carcinogenesis and significance related to human neoplasis. Animal Models for Biomedical Research IV. National Academy of Sciences, Washington, D.C. 1971; 11
   Google Scholar
• Hardy W. D., Jr, Old L. J., Hess P. W., Essex M., Cotter S. Horizontal transmission of feline leukemia virus. Nature 1973; 244: 266
   PubMed Web of Science ®Google Scholar
• Essex M. Horizontally and vertically transmitted oncornaviruses of cats. Adv. Cancer Res. 1975; 21: 175
   Google Scholar
• Nowinski R. C., Edynak E., Sarkar N. H. Serological and structural properties of Mason-Pfizer monkey virus isolated from the mammary tumor of a Rhesus monkey. Proc. Natl. Acad. Sci. U.S.A. 1971; 68: 1608
   Google Scholar
• Old L. J., Stockert E. Immunogenetics of cell surface antigens of mouse leukemia. Ann. Rev. Genet. 1977; 11: 127
   PubMed Web of Science ®Google Scholar
• Hardy W. D., Jr, Hurvitz A. I. Feline infectious peritonitis: experimental studies. J. Am. Vet. Med. Assoc 1971; 158: 994
   Google Scholar
• Hoover E. A., Olsen R. G., Hardy W. D., Jr, Schaller J. P. Brief communication: horizontal transmission of feline leukemia virus under experimental conditions. J. Natl. Cancer Inst. 1977; 58: 443
   Google Scholar
• Essex M., Cotter S. M., Sliski A. H., Hardy W. D., Jr, Stephenson J. R., Aaronson S. A., Jarrett O. Horizontal transmission of feline leukemia virus under natural conditions in a feline leukemia cluster household. Int. J. Cancer 1977; 19: 90
   Google Scholar
• Hardy W. D., Jr, Geering G., Old L. J., DeHarven E., Brodey R. S., McDonough S. K. Serological studies of the feline leukemia virus. Comparative Leukemia Research, Bibl. Haemat.No. 36, Dutcher, R. M., Ed. S. Karger, Basel 1970; 343
   Google Scholar
• Sarma P. S., Baskar J. F., Huebner R. J., Old L. J., Hardy W. D., Jr. Feline leukemia virus: detection of group-specific viral antigen and infectious virus by a complement-fixation test. Comparative Leukemia Research, No. 36 Bibl. Haemal., R. Dutcher. S. Karger, New York 1970; 368
   Google Scholar
• Essex M., Klein G., Snyder S. P., Harrold J. B. Correlation between humoral antibody and regression of tumours induced by feline sarcoma virus. Nature 1971; 233: 195
   PubMed Web of Science ®Google Scholar
• Hardy W. D., Jr, Zuckerman E. E., MacEwen E. G., Hayes A. A., Essex M. A feline leukemia virus-and sarcoma virus-induced tumor-specific antigen. Nature 1977; 270: 249
   PubMed Web of Science ®Google Scholar
• Essex M., Cotter S. M., Carpenter J. L., Hardy W. D., Jr, Hess P., Jarrett W., Schaller J., Yohn D. S. Feline oncornavirus-associated cell membrane antigen. 11. Antibody titers in healthy cats from household and laboratory colony environments. J. Natl. Cancer Inst. 1975; 54: 631
   PubMed Web of Science ®Google Scholar
• Essex M., Cotter S. M., Hardy W. D., Jr, Hess P., Jarrett W., Jarrett O., Mackey L., Laird H., Perryman L., Olsen R. G., Yohn D. S. Feline oncornavirus-associated cell membrane antigen. IV. Antibody titers in cats with naturally occurring leukemia, iynphoma, and other diseases. J. Natl. Cancer Inst. 1975; 55: 463
   Google Scholar
• Grant C, Essex M., Pedersen N. C., Hardy W. D., Jr, Stephenson J. R., Cotter S. M., Theilen G. H. Lysis of feline lymphoma cells by complement-dependent antibodies in feline leukemia virus contact cats. Correlation of lysis and antibodies to feline oncornavirus-associated cell membrane antigen. J. Natl. Cancer Inst. 1978; 60: 161
   PubMedGoogle Scholar
• Grant C. K., DeBoer D. J., Essex M., Worley M. B., Higgins J. Antibodies from healthy cats exposed to feline leukemia virus lyse feline lymphoma cells slowly with cat complement. J. Immunol. 1977; 119: 401
   PubMed Web of Science ®Google Scholar
• Grant C. K., Harris D., Essex M. E., Pickard D. K., Hardy W. D., Jr, de Noronha F. Protection of cats against feline leukemia virus-positive and virus-negative tumors by complement-dependent antibody. J. Natl. Cancer Inst. 1980; 64: 6
   Google Scholar
• Hardy W. D., Jr, Hess P. W., MacEwen E. G., Hayes A. A., Kassel R. L., Day N. K., Old L. J. Treatment of feline lymphosarcoma with feline blood constituents. Comparative Leukemia Research, Bibl. Haemat.No. 43 1975, J. Clemmeson, D. S. Yohn. S. Karger, Basel 1976; 518
   Google Scholar
• Grant C. K., de Noronha F., Tusch C, Michalek M. T., McLane M. F. Protection of cats against progressive fibrosarcomas and persistent leukemia virus infection by vaccination with feline leukemia cells. J. Natl. Cancer Inst. 1980; 65: 6
   Google Scholar
• OldBoyse L. J., Stockert E. Antigenic properties of experimental leukemias. 1. Serological studies in vitro with spontaneous and radiation-induced leukemias. J. Natl. Cancer Inst. 1963; 31: 977
   Google Scholar
• Boyse E. A., Old L. J., Luell S. Antigenic properties of experimental leukemias. II. Immunological studies in vivo with C57BL/6 radiation-induced leukemias. J. Natl. Cancer Inst. 1963; 31: 987
   Web of Science ®Google Scholar
• Boyse E. A., Stockert E., Old L. J. Isoantigens of the H-2 and TLa loci of the mouse. Interactions affecting their representation on thymocytes. J. Exp. Med. 1968; 128: 85
   Google Scholar
• Snell G. D., Stimpfling J. H. Genetics of tissue transplantation. Biology of the Laboratory Mouse2nd Ed., E. Green. McGraw-Hill, New York 1966, chap. 24.
   Google Scholar
• Stockert E., Old L. J., Boyse E. A. The Gix system. A cell surface alloantigen associated with murine leukemia virus: implications regarding the chromosomal integration of the viral genome. J. Exp. Med. 1971; 133: 1334
   PubMed Web of Science ®Google Scholar
• Jacob F. Mouse teratocarcinoma and embryonic antigens. Immunol. Rev. 1977; 33: 3
   Google Scholar
• Burkitt D. A sarcoma involving the jaws in African children. Br. J. Surg. 1958; 46: 218
   PubMed Web of Science ®Google Scholar
• Burkitt D. A lymphoma syndrome in tropical Africa. International Review of Experimental Pathology, G. W. Richter, M. A. Epstein, New York 1963; Vol. 2: 67
   Google Scholar
• Burkitt D. A children's cancer dependent on climatic factors. Nature 1962; 194: 232
   PubMed Web of Science ®Google Scholar
• Epstein M. A., Achong B. G., Barr Y. M. Virus particles in cultured lymphoblasts from Burkitt's lymphoma. Lancet 1964; 1: 702
   PubMed Web of Science ®Google Scholar
• Klein G., Clifford P., Klein E., Smith R. T., Minowada J., Kowrilsky F. M., Burchenal J. H. Membrane immunofluorescence reactions of Burkitt lymphoma cells from biopsy specimens and tissue cultures. J. Natl. Cancer Inst. 1967; 39: 1027
   PubMedGoogle Scholar
• Klein G., Pearson G., Nadkarni J. S., Nadkarni J. J., Klein E., Henle G., Henle W., Clifford P. Relation between Epstein-Barr viral and cell membrane immunofluorescence of Burkitt tumor cells. 1. Dependence of cell membrane immunofluorescence on presence of EB virus. J. Exp. Med. 1968; 128: 1011
   PubMed Web of Science ®Google Scholar
• Goldstein G., Klein G., Pearson G., Clifford P. Direct membrane immunofluorescence reaction of Burkitt lymphoma cells in culture. Cancer Res. 1969; 29: 749
   Google Scholar
• Klein G., Pearson G., Henle G., Henle W., Goldstein G., Clifford P. Relation between EB viral and cell membrane immunofluorescence of Burkitt tumor cells. III. Comparison of blocking of direct membrane immunofluorescence and anti-EBV reactivities of different sera. J. Exp. Med. 1969; 129: 697
   Google Scholar
• Klein G., Clifford P., Henle G., Henle W., Geering G., Old L. J. EBV-associated serological patterns in a Burkitt lymphoma patient during regression and recurrence. Int. J. Cancer 1969; 4: 416
   PubMed Web of Science ®Google Scholar
• Nilsson K., Klein G., Henle W., Henle G. The establishment of lymphoblastoid lives from adult and fetal human lymphoid tissue and its dependence on EBV. Int. J. Cancer 1971; 8: 443
   PubMed Web of Science ®Google Scholar
• Clifford P. On the epidemiology of nasopharyngeal carcinoma. Int. J. Cancer 1970; 5: 287
   PubMed Web of Science ®Google Scholar
• Old L. J., Boyse E. A., Oettgen H. F., DeHarven E., Geering G., Williamson B., Clifford P. Precipitating antibody in human serum to an antigen present in cultured Burkitt's lymphoma cells. Proc. Natl. Acad. Sci. U.S.A. 1966; 56: 1699
   PubMed Web of Science ®Google Scholar
• Becker S. W. Historical background of research on pigmentary disease of the skin. J. Invest. Dermatol. 1959; 32: 185
   Google Scholar
• Szabo G. Quantitative histological investigations on the melanocyte system of the human epidermis. Pigment Cell Biology, M. Gordon. Academic Press, New York 1959; 99
   Google Scholar
• Pinkus H., Staricco R. J., Kropp P. J., Fan J. The symbiosis of melanocytes and human epidermis under normal and abnormal conditions. Pigment Cell Biology, M. Gordon. Academic Press, New York 1959; 127
   Google Scholar
• Marsden C. D. Pigmentation in the nucleus substantia nigrae of mammals. J. Anal. 1961; 95: 256
   Google Scholar
• Macdonald E. J., McGuffee V., White E. Status of epidemiology of melanoma 1971. Pigment Cell., V. Riley. S. Karger, Basel 1973; Vol. 1: 222
   Google Scholar
• Lehman H. E., Youngs L. M. Extrinsic and intrinsic factors influencing amphibian pigment pattern formation. Pigment Cell Biology., M. Gordon. Academic Press, New York 1959; 1
   Google Scholar
• Zimmerman A. A., Becker S. W., Jr. Precursors of epidermal melanocytes in the negro fetus. Pigment Cell Biology, M. Gordon. Academic Press, New York 1959; 159
   Google Scholar
• Bronner M. E., Cohen A. M. Migratory patterns of cloned neural crest melanocytes injected into host chicken embryos. Proc. Natl. Acad. Sci. U.S.A. 1979; 76: 1843
   PubMed Web of Science ®Google Scholar
• Fitzparrick T. B., Breathnach A. S. Das epidermale melanin-einheit-system. Derm. Swchr. 1963; 147: 481
   Google Scholar
• Hadley M. E., Quevedo W. C, Jr. Vertebrate epidermal melanin unit. Nature 1966; 209: 1334
   Google Scholar
• Snell R. S. Hormonal control of pigmentation in man and other mammals. The Pigmentary System, W. Montagna, F. Hu. Pergamon Press, Elmsford, NY 1966, chap. 27.
   Google Scholar
• Pathak M. A., Riley F. C., Fitzpatrick T. B. Melanogenesis in human skin following exposure to long-wave ultraviolet and visible light. J. Invest. Dermatol. 1962; 39: 435
   Google Scholar
• Cruickshank C. N. D., Harcourt S. A. Pigment donation in vitro. Invest. Dermatol. 1964; 42: 183
   Google Scholar
• Klaus S. N. Pigment transfer in mammalian epidermis. Arch. Dermatol. 1969; 100: 756
   PubMedGoogle Scholar
• Thompson M. L. Relative efficiency of pigment and horny layer thickness in protecting the skin of Europeans and Africans against solar ultraviolet light. J. Physiol 1955; 127: 236
   Google Scholar
• Keeler C. E. Albinism, xeroderma pigmentosum and skin cancer. Conf. on Biology of Cutaneous Cancer. U.S. National Cancer Institute, Washington, D.C. 1963; 349
   Google Scholar
• Birdeck M. S. C., Barnicot N. A. Electron microscope studies on pigment formation in human hair follicles. Pigment Cell Biology, M. Gordon. Academic Press, New York 1959; 549
   Google Scholar
• Fitzpatrick T. B., Kukita A. Tyrosinase activity in vertegrate melanocytes. Pigment Cell Biology, M. Gordon. Academic Press, New York 1959; 489
   Google Scholar
• Szabo G., Gerald A. B., Pathak M. A., Fitzpatrick T. B. Racial differences in the fate of melanosomes in human epidermis. Nature 1969; 222: 1081
   PubMedGoogle Scholar
• Toda K., Fitzpatrick T. B. The origin of melanosomes. Biology of Normal and Abnormal Melanocytes, T. Kawamura, T. B. Fitzpatrick, M. Seiji. Univeristy of Tokyo Press, Tokyo 1971; 265
   Google Scholar
• Toda K., Pathak M. A., Parrish J. A., Fitzpatrick T. B., Quevedo W. C. Alteration of racial differences in melanosome distribution after exposure to ultraviolet light. Nature New Biol. 1972; 236: 143
   PubMedGoogle Scholar
• Toda K., Pathak M. A., Fitzpatrick T. B., Quevedo W. C., Morikawa F., Jr., Nakayama Y. Skin color: its ultrastructure and its determining mechanism. Pigment Cell, V. Riley. S. Karger, Basel 1973; Vol. I: 66
   Google Scholar
• Pathak M. A., Hori Y., Szabo G., Fitzpatrick T. B. The photobiology of melanin pigmentation in human skin. Biology of Normal and Abnormal Melanocytes, T. Kawamura, T. B. Fitzpatrick, M. Seiji. University of Tokyo Press, Tokyo 1971; 149
   Google Scholar
• Klaus S. N. Post-transfer digestion of malanosome complexes and saltatory movement of melanin granules within mammalian epidermal cells. J. Invest. Dermatol. 1969; 53: 440
   Google Scholar
• Oettle A. G. Epidermiology of melanomas in South Africa. Structure and Control of the Melanocyte, G. Delia Porta, O. Muhlbock. Springer-Verlag, New York 1966; 292
   Google Scholar
• Macdonald E. J. Malignant melanoma among Negroes and Latin Americans in Texas. Pigment Cell Biology., M. Gordon. Academic Press, New York 1959; 171
   Google Scholar
• Lancaster H. O. Some geographical aspects of the mortality from melanoma in Europeans. Med. J. Aust. 1956; I: 1082
   Google Scholar
• Lancaster H. O., Nelson J. Sunlight as a cause of melanoma: a clinical survey. Med. J. Aust. 1957; 1: 452
   Google Scholar
• Lee J. A. H. Sunlight and the etiology of malignant melanoma. Melanoma and Skin Cancer, W. H. McCarthy. V.C.N. Blight, Syndey 1972; 84
   Google Scholar
• Loomis W. F. Skin pigment regulations of vitamin-D biosynthesis in man. Science 1967; 157: 501
   PubMed Web of Science ®Google Scholar
• Morgan J. E., Gilchrest B., Goldwyn R. M. Skin pigmentation. Current concepts and relevance to plastic surgery. Plasl. Reconsl. Surg. 1975; 56: 617
   Google Scholar
• Clark W. H., Jr, From L., Bernardino E. A., Mihm M. C. The histogenesis and biologic behavior of primary human malignant melanomas of the skin. Cancer Res. 1969; 29: 705
   PubMed Web of Science ®Google Scholar
• Rippey J. J., Rippey E., Giraud R. M. A. Pathology of malignant melanoma of the skin of black Africans, 5. Afr. Med. J. 1975; 49: 789
   Google Scholar
• Reed R. J. Acral lentiginous melanoma. New Concepts in Surgical Pathology of Skin, W. Hartmann, S. Kay, R. J. Reed. John Wiley and Sons, New York 1976; 89
   Google Scholar
• Sober A. J., Mihm M. C., Fitzpatrick T. B., Jr., Clark W. H. Malignant melanoma of the skin, and benign neoplasms and hyperplasias of melanocytes in the skin. Dermatology in General Medicine 2nd ed., T. B. Fitzpatrick, A. Z. Eisen, K. Wolff, I. M. Freedberg, K. F. Austen. McGraw-Hill, New York 1979, chap. 68.
   Google Scholar
• Shields J. A., Federman J. L. Malignant melanoma of the uveal tract. Human Malignant Melanoma, W. H. Clark, L. Goldman, M. J. Mastrangelo. Grune and Stratton, New York 1979; 443
   Google Scholar
• Mandel M. A. Malignant melanoma: an update. Clin. Plast. Surg. 1980; 7: 379
   Google Scholar
• Hutchinson J. Lentigo melanosis. Arch. Surg. 1893–1894; 5: 253
   Google Scholar
• Davis J., Pack G. T., Higgens G. K. Melanotic freckle of Hutchinson. Am. J. Surg. 1967; 113: 457
   PubMedGoogle Scholar
• Clark W. H., Jr, Mihm M. C., Jr. Lentigo maligna and lentigo maligna malanoma. Am. J. Pathol. 1969; 55: 39
   PubMed Web of Science ®Google Scholar
• Clark W. H., Jr, Bernardino E. A., Reed R. J., Kopf A. W. Acral lentiginious melanomas including melanomas of mucous membranes. Human Malignant Melanoma, W. H. Clark, L. I. Goldman, M. J. Mastrangelo. Grune and Stratton, New York 1978; 109
   Google Scholar
• Pliskin M. E. Malignant melanoma of the oral cavity. Human Malignant Melanoma, W. H. Clark, L. Goldman, M. J. Mastrangelo. Grune and Stratton, New York 1978; 125
   Google Scholar
• Scotto J., Fraumeni J. F., Jr, Lee J. A. H. Melanomas of the eye and other non-cutaneous sites: epidemiologic aspects. J. Natl. Cancer Inst. 1976; 56: 489
   PubMedGoogle Scholar
• Kaplan E. N. The risk of malignancy in large congenital nevi. Plast. Reconstr. Surg. 1974; 53: 421
   PubMed Web of Science ®Google Scholar
• Nicholls E. M. Development and elimination of pigmented moles, and the anatomical distribution of primary malignant melanoma. Cancer 1973; 32: 191
   Google Scholar
• Ainsworth A. M., Folberg R., Reed R. J., Clark W. H., Jr. Melanocytic nevi, melanocytomas, melanocytic displasias, and uncommon forms of melanomas. Human Malignant Melanoma, W. H. Clark, L. I. Goldman, M. J. Mastrangelo. Grune and Stratton, New York 1978; 167
   Google Scholar
• Allen A. C., Spitz S. S. Malignant melanoma. A clinicopathological analysis of the criteria for diagnosis and prognosis. Cancer 1953; 6: 1
   PubMed Web of Science ®Google Scholar
• Dark W. H., Jr, Folberg R., Ainsworth A. M. Tumor progression in human cutaneous malignant melanomas. Human Malignant Melanoma, W. H. Clark, Jr, L.I. Goldman, M. J. Mastrangelo. Grune & Stratton, New York 1978; 15
   Google Scholar
• Cawley E. P. Genetic aspects of malignant melanoma. Arch. Derm. 1952; 65: 440
   Google Scholar
• Moschella S. L. A report of malignant melanoma of the skin in sisters. Arch Derm. 1961; 84: 1024
   Google Scholar
• Miller T. R., Pack G. T. The familial aspects of malignant melanoma. Arch. Derm. 1962; 86: 35
   Google Scholar
• Schoch E. P., Jr. Familial malignant melanoma. Arch. Derm. 1963; 88: 445
   Google Scholar
• Turkington R. W. Familial factor in malignant melanoma. JAMA 1965; 192: 77
   Google Scholar
• Katzenellenbogen I., Sandbank M. Malignant melanoma in twins. Arch. Derm. 1966; 94: 331
   Google Scholar
• Anderson D. E., Smith L. J., Jr, McBride C. M. Hereditary aspects of malignant melanoma. JAMA 1967; 200: 741
   Google Scholar
• Wallace D. C., Exton L. A., McLeort G. R. C. Genetic factor in malignant melanoma. Cancer 1971; 27: 1262
   Google Scholar
• Wallace D. C., Beardmore G. L., Exton L. A. Familial malignant melanoma. Ann. Surg. 1972; 72: 15
   Google Scholar
• Reimer R. R., Dark W. H., Jr, Greene M. H., Ainsworth A. M., Fraumeni J. F., Jr. Precursor lesions in familial melanomas. A new genetic preneoplastic lesion. JAMA 1978; 239: 774
   Google Scholar
• Clark W. H., Jr, Reimer R. R., Greene M., Ainsworth A. M., Mastrangelo M. J. Origin of familial malignant melanomas from heritable melanocytic lesions. The B-K mole syndrome. Arch. Dermatol. 1978; 114: 732
   PubMed Web of Science ®Google Scholar
• Lynch H. T., Frichot B. C., III, Lynch J. F. Familial atypical multiple mole-melanoma syndrome. J. Med. Genet. 1710; 15: 352
   Google Scholar
• Lynch H. T., Krush A. J. Heredity and malignant melanoma: implications for early cancer detection. Can. Med. Assoc. J. 1968; 99: 17
   PubMed Web of Science ®Google Scholar
• Bellet R. E., Vaisman I., Mastrangelo M. J., Lustbader E. Multiple primary malignancies in patients with cutaneous melanoma. Cancer 1977; 40: 1974
   PubMed Web of Science ®Google Scholar
• Moseley H. S., Giuliano A. E., Strom F. K., III, Clark W. H., Jr, Robinson D. S., Morton D. H. Multiple primary melanoma. Cancer 1979; 43: 939
   Google Scholar
• Eberhard P. Growth dynamics of malignant melanomas. A photodocumentary investigation. Arch. Dermatol. 1980; 116: 182
   Google Scholar
• Wilbur D. L., Hartman H. R. Malignant melanoma with delayed metastatic growths. Ann. Int. Med. 1931; 5: 201
   Google Scholar
• Wigle D. T. Malignant melanoma of skin and sunspot activity. Lancet 1978; 2: 38, 143a. Houghton, A., personal communication.
   Google Scholar
• Beardmore G. L. The epidemiology of malignant melanoma in Australia. Melanoma and Skin Cancer, W. H. McCarthy. V.C.N. Blight, Syndey 1972; 39
   Google Scholar
• Elwood J. H., Lee J. A. H. Recent data on the epidemiology of malignant melanoma. Sem. Oncol 1975; 2: 149
   PubMedGoogle Scholar
• Magnus K. Incidence of malignant melanoma of the skin in the five Nordic countries: significance of solar radiation. Int. J. Cancer 1977; 20: 477
   PubMed Web of Science ®Google Scholar
• Malec E., Eklund G. The changing incidence of malignant melanoma of the skin in Sweden 1959–1968. Scand. J. Plast. Reconstr. Surg. 1978; 12: 19
   PubMed Web of Science ®Google Scholar
• Lee J. A. H., Merrill J. M. Sunlight and the aetiology of malignant melanoma: a synthesis. Med. J. Aust. 1970; 2: 846
   PubMed Web of Science ®Google Scholar
• Dickson D. Melanoma increase in radiation labs?. Nature 1980; 287: 475
   Google Scholar
• Gellin G. A., Kopf A. W., Garflnkel L. Malignant melanoma. A controlled study of possible associated factors. Arch. Derm. 1969; 99: 43
   PubMedGoogle Scholar
• Everson T. C. Spontaneous regression of cancer. Ann. N.Y. Acad. Sci. 1964; 114: 721
   Web of Science ®Google Scholar
• Everson T. C., Cole W. H. Spontaneous Regression of Cancer. W. B. Saunders, Philadelphia 1966, chap. 4.
   Google Scholar
• Nathanson L. Spontaneous regression of malignant melanoma: a review of the, literature on incidence, clinical features, and possible mechanisms. Natl. Cancer Inst. Monogr. 1976; 44: 67
   PubMedGoogle Scholar
• Cole W. H. Opening address: spontaneous regression of cancer and the importance of finding its cause. Natl. Cancer Inst. Monogr. 1976; 44: 5
   Google Scholar
• Sumner W. C. Spontaneous regression of melanoma. Cancer 1953; 6: 1040
   Google Scholar
• Sumner W. C., Foraker A. G. Spontaneous regression of human melanoma. Cancer 1960; 13: 79
   PubMedGoogle Scholar
• Allen E. P. Malignant melanoma. Spontaneous regression after pregnancy. Br. Med. J. 1955; 2: 1067
   PubMedGoogle Scholar
• Ikonopisov R. L. Morphologic patterns of spontaneously regressing malignant melanoma in relation to host immune reactions. Pigment Cell, V. Riley. S. Karger, Basel 1973; Vol. 1: 402
   Google Scholar
• Doyle J. C., Bennett R. C., Newing R. K. Spontaneous regression of malignant melanoma. Med. J. Aust. 1973; 2: 551
   PubMedGoogle Scholar
• Foley W. J., Coon W. W. Unusual clinical course in patients with malignant melanoma. Mich. Med. 1970; 69: 763
   Google Scholar
• Smith J. L., Jr, Stelin J. S., Jr. Spontaneous regression of primary malignant melanomas with regional metastases. Cancer 1965; 18: 1399
   PubMed Web of Science ®Google Scholar
• Pellegrini A. E. Regressed primary malignant melanoma with regional metastases. Arch. Derm. 1980; 116: 585
   Google Scholar
• Cochran A. J. Malignant melanoma. A review of 10 years experience in Glascow, Scotland. Cancer 1969; 23: 1190
   Google Scholar
• Huvos A. G., Shah J. P., Mike V. Prognostic factors in cutaneous malignant melanoma. A comparative study of long term and short term survivors. Human Pathol. 1974; 5: 67
   Google Scholar
• Shaw H. M., Milton G. W., Farago G., McCarthy W. H. Endocrine influences on survival from malignant melanoma. Cancer 1978; 42: 669
   PubMed Web of Science ®Google Scholar
• Pack G. T., Scharnagel I. M. The prognosis for malignant melanoma in the pregnant woman. Cancer 1951; 4: 324
   PubMedGoogle Scholar
• Byrd B. F., Jr, McGarrity W. J. The effect of pregnancy of clinical course of malignant melanoma. S. Med. J. 1954; 47: 196
   PubMedGoogle Scholar
• Shiu M. H., Schottenfeld D., McClean B., Fortner J. G. Adverse effect of pregnancy on melanoma. A reappraisal. Cancer 1976; 37: 181
   PubMed Web of Science ®Google Scholar
• Sadoff L., Winkley J., Tyson S. Is malignant melanoma an endocrine-dependent tumor?. Oncology 1973; 27: 244
   Google Scholar
• Little J. H. Histology and prognosis in cutaneous malignant melanoma. Melanoma and Skin Cancer, W. H. McCarthey. V.C.N, Blight 1972; 107
   Google Scholar
• Thompson P. G. Relationship of lymphocytic infiltration to prognosis in primary malignant melanoma of skin. Pigment Cell, V. Riley. S. Karger, Basel 1973; Vol. 1: 285
   Google Scholar
• Roubin R., Cesarini F. P., Fridman W. H., Pavie-Fischer J., Peter H. H. Characterization of the mononuclear cell infiltrate in human malignant melanoma. Int. J. Cancer 1975; 16: 61
   Google Scholar
• Bodurtha A. J., Berkelhammer J., Kim Y. H., Laucius J. F., Mastrangelo M. J. A clinical, histologic, and immunologic study of a case of metastatic melanoma undergoing spontaneous regression. Cancer 1976; 37: 735
   Google Scholar
• Lewis M. G. Possible immunological factors in human malignant melanoma in Uganda. Lancet 1967; 11: 921
   Google Scholar
• Morton D. L., Malmgren R. A., Holmes E. C., Ketcham A. S. Demonstration of antibodies against human malignant melanoma by immunofluorescence. Surgery. 1968; 64: 233
   PubMed Web of Science ®Google Scholar
• Whitehouse J. M. A. Circulating antibodies in human malignant disease. Br. J. Cancer 1973; 28(Suppl. 1)170
   Google Scholar
• Lewis M. G., Ikonopisov R. L., Nairn R. C., Phillips T. M., Hamilton-Fairley G., Bodenham D. C., Alexander P. Tumour-specific antibodies in human malignant melanoma and their relationship to the extent of disease. Br. Med. J. 1969; 3: 547
   PubMed Web of Science ®Google Scholar
• Romsdahl M. M., Cox I. S. Human malignant melanoma antibodies demonstrated by immunofluorescence. Arch. Surg. 1970; 100: 491
   PubMedGoogle Scholar
• Morton D. L., Eilber F. R., Malmgren R. A. Immune factors in human cancer: malignant melanomas, skeletal and soft tissue sarcomas. Prog. Exp. Tumor Res. 1971; 14: 25
   Google Scholar
• Oettgen H. F., Aoki T., Old L. J., Boyse E. A., DeHarven E., Mills G. Suspension culture of a pigment-producing cell line derived from a human malignant melanoma. J. Natl. Cancer Inst. 1968; 41: 827
   Google Scholar
• Muna N. M., Marcus S., Smart C. Detection by immunofluorescence of antibodies for human malignant melanoma cells. Cancer 1969; 23: 88
   PubMed Web of Science ®Google Scholar
• Nairn R. C., Nind A. P. P., Guli E. P. G., Davies D. J., Little J. H., Davis N. C., Whitehead R. H. Anti-tumour immunoreactivity in patients with malignant melanoma. Med. J. Aust. 1972; 1: 397
   PubMed Web of Science ®Google Scholar
• Whitehead R. H. Fluorescent antibody studies in malignant melanoma. Br. J. Cancer 1973; 28: 525
   Google Scholar
• Bourgoin J. J., Bourgoin A. Cytoplasmic antigens in human malignant melanoma cells. Pigment Cell, V. Riley. S. Karger, Basel 1973; 366
   Google Scholar
• Wood G. W., Barth R. F. Immunofluorescent studies of the serologic reactivity of patients with malignant melanoma against tumor-associated cytoplasmic antigens. J. Nail. Cancer Inst. 1974; 53: 309
   Google Scholar
• Peter H. H., Kalden J. R., Seeland P., Diehl V., Eckert G. Humoral and cellular immune reactions in vitro against allogeneic and autologous human melanoma cells. Clin. Exp. Immunol. 1975; 20: 193
   Google Scholar
• Bodurtha A. J., Chee D. O., Laucius J. F., Mastrangelo M. J., Prehn R. T. Clinical and immunological significance of human melanoma cytotoxic antibody. Cancer Res. 1975; 35: 189
   PubMed Web of Science ®Google Scholar
• Canevari S., Fossati G., Delia Porta G., Balzarini G. P. Humoral cytotoxicity in melanoma patients and its correlation with the extent and course of disease. Int. J. Cancer. 1975; 16: 722
   Google Scholar
• Cornain S., DeVries J. E., Collard J., Vennegoor C., van Wingerden I., Rumke P. Antibodies and antigen expression in human melanoma detected by the immune adherence test. Int. J. Cancer 1975; 16: 981
   Google Scholar
• Leong S. P. L., Sutherland C. M., Krementz E. T. Immunofluorescent detection of common melanoma membrane antigens by sera of melanoma patients immunized against autologous or allogeneic cultured melanoma cells. Cancer Res. 1977; 37: 4035
   Google Scholar
• Liao S.-K., Leong S. P. L., Sutherland C. M., Dent D. B., Kwong P. C., Krementz E. T. Common human melanoma membrane antigens detected by mixed hemadsorption microassay with serum from a patient undergoing immunotherapy with autologous tumor cells. Cancer Res. 1978; 38: 4395
   Google Scholar
• The T. H., Huiges H. A., Schraffordt-Koops H., Lamberts H. B., Nieweg H. O. Surface antigens on cultured malignant melanoma cells as detected by a membrane immunofluorescence method with human sera. Lack of tumor-specific reactions on melanoma lines. Ann. N. Y. Acad. Sci. 1975; 254: 528
   Google Scholar
• Seibert E., Sorg C, Happle R., Macher E. Membrane associated antigens of human malignant melanoma. III. Specificity of human sera reacting with cultured melanoma cells. Int. J. Cancer. 1977; 19: 172
   Google Scholar
• Saxton R. E., Irie R. F., Ferrone S., Pellegrino M. A., Morton D. L. Establishment of paired tumor cells and autologous virus-transformed cell lines to define humoral immune responses in melanoma and sarcoma patients. Int. J. Cancer 1978; 21: 299
   Google Scholar
• Hellstrom I., Hellstrom K. E., Sjogren H. O., Warner G. A. Demonstration of cell-mediated immunity to human neoplasms of various histological types. Int. J. Cancer. 1971; 7: 1
   PubMed Web of Science ®Google Scholar
• Currie G. A., Lejeune F., Hamilton-Fairley G. Immunization with irradiated tumour cells and specific lymphocyte cytotoxicity in malignant melanoma. Br. Med. J. 1971; 2: 305
   PubMedGoogle Scholar
• Fossati G., Colnaghi M. I., Delia Porta G., Cascinelli N., Veronesi U. Cellular and humoral immunity against human malignant melanoma. Int. J. Cancer 1971; 8: 344
   PubMedGoogle Scholar
• de Vries J. E., Meyering M., Dongen A. V., Rumke P. The influence of different isolation procedures and the use of target cells from melanoma cell lines and short-term cultures on the nonspecific cytotoxic effectors of lymphocytes from healthy donors. Int. J. Cancer 1975; 15: 391
   PubMedGoogle Scholar
• Hersey P., Edwards A., Edwards J., Adams E., Milton G. W., Nelson D. S. Specificity of cell-mediated cytotoxicity against human melanoma lines: evidence of “non-specific” killing by activated T-cells. Int. J. Cancer 1975; 16: 173
   Google Scholar
• Berkelhammer J., Mastrangelo M. J., Laucius J. F., Bodurtha A. J., Prehn R. T. Sequential in vitro reactivity of lymphocytes from patients receiving immunotherapy compared with the reactivity of lymphocytes from normal donors. Int. J. Cancer 1975; 16: 571
   Google Scholar
• de Vries J. E., Rumke P. Tumour-associated lymphocyte cytotoxicity superimposed on “spontaneous” cytotoxicity in melanoma patients. Int. J. Cancer. 1976; 17: 182
   Google Scholar
• Herberman R. B., Nurm M. E., Holden H. T., Lavrin D. H. Natural cytotoxic reactivity of mouse lymphoid cells against syngeneic and allogeneic tumors. II. Characterization of effector cells. Int. J. Cancer 1975; 16: 230
   PubMed Web of Science ®Google Scholar
• Heppner G., Henry E., Stolbach L., Cummings F., McDonough E., Calabresi P. Problems in the clinical use of the microcytotoxicity assay for measuring cell-mediated immunity to tumor cells. Cancer Res. 1975; 35: 1931
   Google Scholar
• Shiku H., Kiselow P., Bean M. A., Takahashi T., Boyse E. A., Oettgen H. F., Old L. J. Expression of T-cell differentiation antigens on effector cells in ceii-mediated cytotoxicity in vitro. Evidence of functional heterogeneity related to the surface phenotype of T-cells. J. Exp. Med. 1975; 141: 227
   Google Scholar
• Livingston P. O., Shiku H., Bean M. A., Pinsky C. M., Oettgen H. F., Old L. J. Cell mediated cytotoxicity for cultured autologous melanoma cells. Int. J. Cancer. 1979; 24: 34
   PubMed Web of Science ®Google Scholar
• Carey T. E., Takahashi T., Resnick L. A., Oettgen H. F., Old L. J. Cell surface antigens of human malignant melanoma: mixed hemadsorption assays for humora immunity to cultured autologous melanoma cells. Proc. Natl. Acad. Sci. U.S.A. 1976; 73: 3278
   PubMed Web of Science ®Google Scholar
• Espmark A., Fagreus A. Detection of antigens in tissue culture with the aid of mixed hemadsorption. Acta Pathol. Microbiol. Scand. Suppl. 1962; 154: 258
   Google Scholar
• Carey T. E., Lloyd K. O., Takahashi T., Travassos L. R., Old L. J. AU cell-surface antigen of human malignant melanoma: solubilization and partial characterization. Proc. Natl. Acad. Sci. U.S.A. 1979; 76: 2898
   PubMed Web of Science ®Google Scholar
• Shiku H., Takahashi T., Oettgen H. F., Old L. J. Cell surface antigens of human malignant melanoma. II. Serologic typing with immune adherence assays and definition of two new surface antigens. J. Exp. Med. 1997; 144: 873
   Google Scholar
• Shiku H., Takahashi T., Resnick L. A., Oettgen H. F., Old L. J. Cell surface antigens of human malignant melanoma. III. Recognition of autoantibodies with unusual characteristics. J. Exp. Med. 1977; 145: 784
   Google Scholar
• Pinsky C. M., Hirshaut Y., Wanebo H. J., Fortner J. G., Mike V., Schottenfeld D., Oettgen H. F. Randomized trial of Bacillus Calmette-Guerin (percutaneous administration) as surgical aduvant immunotherapy for patients with state 11 melanoma. Ann. N. Y. Acad. Sci. 1976; 211: 187
   Google Scholar
• Kornbluth J., Pollack M. S., Fogh J., Carey T., DuPont B. HLA typing of human tumor cell lines: selection of appropriate typing techniques. Trans. Proc 1978; 10: 735
   Google Scholar
• Pollack M. S., Livingston P. O., Fogh J., Carey T. E., Oettgen H. F., DuPont B. Genetically appropriate expression of HLA and DR (IA) alloantigens on human melanoma cell lines. Tissue Antigens 1980; 15: 249
   Google Scholar
• Takahashi T., Carey T. E., Resnick L. A., Lloyd K. O., Oettgen H. F., Old L. J. Serological study of a patient with malignant malanoma. Definition of an individually specific malanoma antigen-AU. Immunobiology and Immunotherapy of Cancer, W. D. Terry, Y. Yamamura. Elsevier, New York 1979; 205
   Google Scholar
• Shiku H., Takahashi T., Carey T. E., Resnick L. A., Oettgen H. F., Old L. J. Cell surface antigens of human cancer. Biological Markers of Neoplasia: Basic and Applied Aspects, R. Ruddon. Elsevier, New York 1978; 73
   Google Scholar
• Garrett T. J., Takahashi T., Clarkson B. D., Old L. J. Detection of antibody to autologous human leukemia cells by immune adherence assays. Proc. Natl. Acad. Sci. U.S.A. 1977; 74: 4587
   Google Scholar
• Pfreundschuh M., Shiku H., Takahashi T., Ueda R., Ransohoff J., Oettgen H. F., Old L. J. Serological anaylsis of cell surface antigens of malignant human brain tumors. Proc. Natl. Acad. Sci. U.S.A. 1978; 75: 5122
   PubMedGoogle Scholar
• Ueda R., Shiku H., Pfreundschuh M., Takahashi T., Li L. T., Whitmore W. F., Oettgen H. F., Old L. J. Cell surface antigens of human renal cancer defined by autologous typing. J. Exp. Med. 1979; 150: 564
   PubMed Web of Science ®Google Scholar
• Bean M. A., Bloom B. R., Herberman R. B., Old L. J., Oettgen H. F., Klein G., Terry W. D. Cell-mediated cytotoxicity for bladder carcinoma: evaluation of a workshop. Cancer Res. 1975; 35: 2902
   PubMedGoogle Scholar
• Houghton A. N., Oettgen H. F., Old L. J. Malignant melanoma. Current status of the search for melanoma specific antigens. Immunodermalology, B. Safai, R. A. Good. Plenum Press, New York 1981, chap. 39.
   Google Scholar
• Zbar B., Bernstein I. D., Rapp H. J. Suppression of tumor growth at the site of infection with living Bacillus Calmette-Guerin. J. Natl. Cancer Inst. 1971; 46: 831
   PubMedGoogle Scholar
• Zbar B., Bernstein I. D., Bartlett G. L., Hanna M. G., Jr, Rapp H. J. Immunotherapy of cancer: regression of intradermal tumors and prevention of growth of lymph node metastases after intralesional injection of living Mycobacterium bovis. J. Natl. Cancer Inst. 1972; 49: 119
   PubMedGoogle Scholar
• Smith H. G., Bast R. C., Zbar B., Jr., Rapp H. J. Eradication of microscopic lymph node metastases after injection of living BCG adjacent to the primary tumor. J. Natl. Cancer Inst. 1975; 55: 1345
   Google Scholar
• Shiku H., Takahashi T., Carey T., Resnick L., Pfreundschuh M., Ueda R., Oettgen H. F., Old L. J. Definition of cell surface antigens of human malignant melanoma, astrocytoma and renal cancer by typing with autologous serum. Serologic Analysis of Human Cancer Antigens, S. A. Rosenberg. Academic Press, New York 1980, 305
   Google Scholar
• Old L. J. Cancer immunology: the search for specificity - G.H.A. Clowes Memorial Lecture. Cancer Res. 1981; 41: 361
   PubMed Web of Science ®Google Scholar
• Watanabe T., personal communication.
   Google Scholar
• Irie R. F., Irie K., Morton D. L. Natural antibody in human serum to a neoantigen in human cultured cells grown in fetal bovine serum. J. Nail. Cancer Inst. 1974; 52: 1051
   Google Scholar
• Irie K., Irie R. F., Morton D. L. Humoral immune response to melanoma-associated membrane antigen and fetal brain antigen demonstrated by indirect membrane immunofluorescence. Cancer Immunol. Immunother. 1979; 6: 33
   Google Scholar
• Jones P. C., Sze L. L., Liu P. Y., Morton D. L., Irie R. F. Prolonged survival for melanoma patients with elevated IgM antibody to oncofetal antigen. J. Nail. Cancer Inst. 1981; 66: 249
   PubMed Web of Science ®Google Scholar
• Houghton A. N., Taormina M. C., Ikeda H., Watanabe T., Oettgen H. F., Old L. J. Serological survey of normal humans for natural antibody to cell surface antigens of melanoma. Proc. Nail. Acad. Sci. U.S.A. 1980; 77: 4260
   PubMed Web of Science ®Google Scholar
• Kohler G., Milstein C. Continuous cultures of fused cells secreting antibody of predefined specificity. Nature 1975; 256: 495
   PubMed Web of Science ®Google Scholar
• Koprowski H., Steplewski Z., Herlyn D., Herlyn M. Study of antibodies against human melanoma produced by somatic cell hybrids. Proc. Natl. Acad. Sci. U.S.A. 1978; 75: 3405
   PubMed Web of Science ®Google Scholar
• Wilson B. S., Imai K., Natali P.-G, Kay N. E., Cavaliere R., Pellegrino M., Ferrone S. Immunochemical analysis of the antigenic profile of human melanoma cells with monoclonal antibodies. Melanoma Anligens and Antibodies, R. A. Reisfeld, S. Ferrone. Plenum Press, New York
   Google Scholar
• Woodbury R. G., Brown J. P., Yeh M. Y., Hellstrom I., Hellstrom K. E. Identification of a cell surface protein, p. 97, in human melanomas and certain other neoplasms. Proc. Natl. Acad. Sci. U.S.A. 1980; 77: 2183
   PubMed Web of Science ®Google Scholar
• Yeh M.-Y., Hellstrom I., Brown J. P., Warner G. A., Hansen J. A., Hellstrom K. E. Cell surface antigens of human melanoma identified by monoclonal antibody. Proc. Natl. Acad. Sci. U.S.A. 1979; 76: 2927
   PubMed Web of Science ®Google Scholar
• Carrel S., Accolla R. S., Carmagnola, A. L., Mach, J. P., Common melanoma-associated antigen(s) detected by monoclonal antibodies. Cancer Res. 1980; 40: 2523
   PubMed Web of Science ®Google Scholar
• Dippold W. G., Lloyd K. O., Li L. T., Cikeda H., Oettgen H. F., Old L. J. Cell surface antigens of human malignant melanoma: definition of six antigenic systems with monoclonal antibodies. Proc. Natl. Acad. Sci. U.S.A. 1980; 11: 6114
   Google Scholar
• Liao S. K., Clarke B. J., Kwong P. C., Brickenden A., Gallie B., Dent D. B. Common neuroectodermal antigens on human melanoma, neuroblastoma, retinoblastoma, glioblastoma and fetal brain revealed by hybridoma antibodies raised against melanoma cells. Eur. J. Immunol. 1981; 11: 450
   Google Scholar
• Olsson L., Kaplan H. S. Human-human hybridomas producing monoclonal antibodies of predefined specificity. Proc. Natl. Acad. Sci. U.S.A. 1980; 11: 5429
   Google Scholar
• Miller G., Lipman M. Release of infectious Epstein-Barr virus by transformed marmoset leukocytes. Proc. Natl. Acad. Sci. U.S.A. 1973; 70: 190
   PubMed Web of Science ®Google Scholar
• Steinitz M., Klein G., Koskimies S., Makel O. EB virus-induced B lymphocyte cell lines producing specific antibody. Nature 1977; 269: 420
   PubMed Web of Science ®Google Scholar